🧐 Q-Line Biotech IPO details and performance check

Q-Line Biotech is launching its maiden IPO for 6,253,200 equity shares at a price band of Rs. 326 - Rs. 343 per share. The company, based in India, is involved in manufacturing diverse IVD reagents and consumables. The IPO opens on May 21, 2026, and closes on May 25, 2026, aiming to mobilize Rs. 214.48 cr. Although top lines grew, FY25 bottom line saw a setback due to accounting adjustments. Investors can consider moderate long-term funds given its current financial standing. 🧐

🎾 Bopanna questions rankings after tennis squad cuts

Two-time Asian Games gold medallist Rohan Bopanna criticized the sports ministry's new rule for the 2026 Asian Games. The guidelines restricted the tennis squad to only those ranked in the top eight in Asia. Consequently, five players, including Manas Dhamne and Vaishnavi Adkar, were excluded from the selection. Bopanna questioned the value of rankings when outcomes are decided by a committee without on-court evidence. The 2026 Asian Games are scheduled to start on September 19 in Aichi-Nagoya, Japan. 🎾

🚗 Suzuki e Sky electric kei car debuts with 310km range

Suzuki unveiled the e Sky, a compact battery-electric kei car designed mainly for the Japanese market. It was introduced by Suzuki's Japanese dealer network, with a planned debut in autumn 2026. The car boasts a claimed driving range of 310 km and weighs just 1,030 kg. This model is built for everyday commuting while featuring a heat pump and V2L capability. The future availability of this specific model in India remains uncertain. 🚗

🏅 PM Modi to connect with youth on National Sports Day

Prime Minister Narendra Modi will address the nation's youth across over 1500 locations on Thursday, August 27, 2026. This event is part of 'Khelo India Samvaad – Khel Ki Baat, PM Ke Saath', leading up to National Sports Day on August 29. The program aims to create a direct dialogue between youth and policymakers, featuring insights from athletes like P.T. Usha and Mary Kom. Youth will share ideas on four themes, including grassroots sports and Olympic talent nurturing. All suggestions gathered will be directly presented to policymakers for action. 🏅

🏏 Cricket legends ask govt for Imran Khan's proper care

Twenty-one global cricket captains urged the Pakistani government to ensure Imran Khan receives humane treatment and proper medical care. The appeal was addressed to Prime Minister Shehbaz Sharif regarding the 73-year-old former PM, who has been imprisoned for three years. The letter, dated August 23, followed a Supreme Court order for his transfer to a private hospital. The signatories stressed that completing the court-ordered medical process is a matter of basic decency. They demanded an independent health assessment and reinstatement of weekly family visits. 🏏

🏏 Jaiswal and Asitha fined after on-field clash

Yashasvi Jaiswal and Asitha Fernando were penalized after an on-field confrontation during the Colombo Test match. The incident occurred when Asitha dismissed Jaiswal on the first morning in Colombo. Both players received a 25% fine of their match fees and a demerit point. This breach was against ICC's code of conduct, with video showing Jaiswal initiated the physical contact. India currently leads the two-Test series 1-0 after winning the first Test in Galle by 165 runs. 🏏

🏆 13-year-old UAE student wins gold with AI education platform

A 13-year-old student from Sharjah, UAE, developed an AI-powered education platform called ScoolBot. Initially called FutureEduAI, the platform was built based on the student's question about student engagement. After initial success in competitions, ScoolBot won Gold at the International AI Awards 2026. He also built Bothread, a free, open-source tool to help multiple AI coding agents coordinate. This journey shows the value of continuous iteration and experimentation in tech. 🚀

🚨 What happens when FSSAI suspends a food business?

FSSAI suspends a food eatery's license due to severe non-compliance with food safety standards or unhygienic conditions. This regulatory action, governed by the Food Safety and Standards Act, 2006, can be imposed immediately or after failing to meet an Improvement Notice. Operation halts instantly, affecting revenue and disrupting employees and suppliers. Businesses must rectify deficiencies and submit a compliance report for re-inspection. Failure to comply can lead to permanent license cancellation after a three-month waiting period.

🗳️ Congress needs to ditch SP for UP 2027 strategy

The article suggests that the Congress party should cease its alliance with the Samajwadi Party for the 2027 elections in Uttar Pradesh. This strategic shift would position Congress to run independently in the state polls. The proposal specifically advocates for Priyanka Gandhi to take on the role of the Chief Minister candidate. This move aims to strengthen Congress's independent political standing in the region. Moving forward, this strategy could redefine the political landscape of UP ahead of the 2027 vote.

🏛️ SC orders probe into JPSC exam issues

The Supreme Court issued notices to the Centre and State government regarding alleged malpractice in the Jharkhand Combined Civil Services Preliminary Examination. This action was taken on Monday, August 24, 2026, based on a petition by activist Harisharan Devgan. The plea specifically demands a time-bound and impartial investigation by the CBI or a former judge. The controversy involves the integrity of the 2025 examination, conducted by the Jharkhand Public Service Commission under Advertisement No. 01/2026. The petitioners are seeking an objective determination of the irregularities' extent before relying on the results. 🧐

🧠 Blood test cleared by FDA for early Alzheimer's detection

C2N Diagnostics received US FDA approval for its PrecivityAD2 test, marking a significant step for Alzheimer's diagnosis. This test is for adults aged 40 and older showing cognitive symptoms, and it was announced on Monday, August 24, 2026, in St. Louis. The test showed a 97.6% positive predictive value in a study of 1,142 subjects. It aims to provide an accessible blood-based option to identify amyloid pathology for healthcare professionals. The FDA-cleared version is expected to be available later this year. 🧠